One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Original oral ganciclovir schedules are not oral valganciclovir schedules. The source grouping of HD and PD is preserved and flagged for modality-specific revalidation.
Exactly 70 is unassigned. Use total body weight unless >120% of ideal, then adjusted weight per this source. Continuous-flow changes require reassessment.
| CrCl, mL/min | Source-specific dose / instruction |
|---|---|
| >70 | 5 mg/kg every 12 hours |
| 50-69 | 2.5 mg/kg every 12 hours |
| 25-49 | 2.5 mg/kg every 24 hours |
| 10-24 | 1.25 mg/kg every 24 hours |
| CrCl, mL/min | Source-specific dose / instruction |
|---|---|
| >70 | 5 mg/kg every 24 hours |
| 50-69 | 2.5 mg/kg every 24 hours |
| 25-49 | 1.25 mg/kg every 24 hours |
| 10-24 | 0.625 mg/kg every 24 hours |
| Dialysis setting / indication | Source-specific schedule |
|---|---|
| IHD treatment | 1.25 mg/kg initially and after HD |
| IHD prevention | 0.625 mg/kg initially and after HD |
| Continuous HD treatment | 2.5 mg/kg every 12 hours |
| Continuous HD prevention | 2.5 mg/kg every 24 hours |
CrCl bands: >70 / 50-69 / 25-49 / 10-24 mL/min. CMV treatment: 5 mg/kg every 12 hours / 2.5 mg/kg every 12 hours / 2.5 mg/kg daily / 1.25 mg/kg daily. Prevention: 5 / 2.5 / 1.25 / 0.625 mg/kg daily. Exactly 70 is not assigned in the displayed bands.
Intermittent-HD treatment: 1.25 mg/kg initially and after HD; prevention: 0.625 mg/kg initially and after HD. Continuous-HD treatment: 2.5 mg/kg every 12 hours; prevention: 2.5 mg/kg daily. Continuous-flow changes require individualized reassessment.
Use total body weight unless it exceeds 120% of ideal body weight, when the source uses adjusted weight. All doses here are IV.
RDM30-027-ganciclovir-1 · Source locator: UCSF - intravenous ganciclovir; renal/dosing sections and stated qualifiers
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=ganciclovir&s1=RDM30-027-ganciclovir&h1=1e1ff2b1c1d2ec142f12679b52de7c2daedc0f2c30120b75eb78b320e7509247